Collectively, our data show that circNHSL1 acts as an oncogenic gene in gastric cancer progression through miR-1306-3p/SIX1/Vimentin axis, and may serve as a novel diagnostic marker and target for treatment of gastric cancer patients. The gene discussed is VIM; the disease is gastric cancer.